By Scientia Professor John Martin Kaldor

Journal articles

Dore GJ; Kaldor JM; Mccaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C', British Medical Journal: International, pp. 553 - 554

Ashton LJ; Carr AD; Cunningham PH; Roggensack M; Mclean K; Law MG; Robertson M; Cooper DA; Kaldor JM, 1998, 'Predictors of progression in long-term nonprogressors.', AIDS Research and Human Retroviruses, 14, pp. 117 - 121

Dowsett GW; Kaldor J; McInnes D; Spongberg M, 1998, 'Queer theory, politics and HIV/AIDS', Metascience, 7, pp. 444 - 465, http://dx.doi.org/10.1007/bf02910957

Kaldor JM, 1998, 'Review Symposia. Commentary on ¿Waldby C. AIDS and the body politic, biomedicine and sexual difference. London Routledge, 1996.¿', Metascience, pp. 448 - 472

Grulich A; Wan X; Law M; Milliken S; Lewis C; Garsia R; Gold J; Finlayson R; Cooper DA; Kaldor JM, 1998, 'RISK FACTORS FOR AIDS ASSOCIATED NON-HODGKIN'S LYMPHOMA: A CASE-CONTROL STUDY.', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 17, pp. A39 - A39, http://dx.doi.org/10.1097/00042560-199804010-00127

Dore GJ; Kaldor JM, 1998, 'Sexually transmissible diseases surveillance in Australia: towards a coordinated national system', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, pp. 49 - 52

Law MG; Downs AM; Brunet J; Kaldor JM, 1998, 'Time trends in HIV infection among pregnant women in Europe', AIDS, 12, pp. 211 - 216

Dore GJ; Li YW; Plant AJ; Kaldor JM, 1998, 'Trends in infectious disease mortality in Australia, 1979-1994', Medical Journal of Australia, 168, pp. 601 - 604

Dore GJ; Li YW; Plant AJ; Kaldor JM, 1998, 'Trends in infectious disease mortality rates', Medical Journal of Australia, 169, pp. 444 - 445

Aguado JM; Pulido F; Dore GJ; Law MG; Kaldor JM; Gordin F; Matts J, 1997, 'Isoniazid prophylaxis for high-risk patients with anergy and HIV infection [4] (multiple letters)', New England Journal of Medicine, 337, pp. 1696 - 1697, http://dx.doi.org/10.1056/NEJM199712043372316

Dore GJ; Law MG; Kaldor JM, 1997, 'Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.', New England Journal of Medicine, 337, pp. 1697

Law MG; Kaldor JM, 1997, 'Survival analysis of randomized clinical trials adjusted for patients who switch treatments - Reply', STATISTICS IN MEDICINE, 16, pp. 2620 - 2621, http://dx.doi.org/10.1002/(SICI)1097-0258(19971130)16:22<2620::AID-SIM1699>3.0.CO;2-4

Porter K; Law MG; Kaldor JM; Lepri AC; Phillips AN; Pezzotti P; Rezza G; Sinicco A; Fora R; Raiteri R; Sciandra M; Bechis G; Calvo MM; Gioannini P, 1997, 'Is the clinical course of HIV infection changing?', BMJ, 315, pp. 1236, http://dx.doi.org/10.1136/bmj.315.7117.1236a

Law MG; Kaldor JM, 1997, 'Is the clinical course of HIV infection changing? Exclusion of people not followed up for 12 months may have biased results.', BMJ (Clinical research ed.), 315, pp. 1236 - 1237

MacDonald M; Wodak AD; Ali R; Crofts N; Cunningham PH; Dolan KA; Kelaher M; Loxley WM; van Beek I; Kaldor JM, 1997, 'HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges.', Med J Aust, 166, pp. 237 - 240, https://www.ncbi.nlm.nih.gov/pubmed/9076266

Harris PJ; Russo IH; Grulich AE; Kaldor JM; Gill PS; Lunardi- Iskandar Y; Gallo RC; Krown SE; Rabkin CS, 1997, 'Intralesional human chorionic gonadotropin for Kaposi's sarcoma [2] (multiple letters)', Journal of Materials Science Materials in Medicine, 8, pp. 1187 - 1189

McNulty A; Rowbottom J; Kaldor J, 1997, 'Sentinel sexually transmitted diseases surveillance at sexual health clinics', Venereology, 10, pp. 11 - 13

Gray JA; Dore GJ; Li Y; Supawitkul S; Effler P; Kaldor JM, 1997, '"HIV-1 Infection among Female Commercial Sex Workers in Rural Thailand."', Studies in Family Planning, 28, pp. 168 - 168, http://dx.doi.org/10.2307/2138125

Dore GJ; Law MG; Kaldor JM, 1997, 'A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis', New England Journal of Medicine, pp. 315 - 320

Law MG; Kaldor JM, 1997, 'A note on the grouping of surveillance data when adjusting for reporting delays', American Journal of Epidemiology, 146, pp. 592 - 595

Veugelers PJ; Strathdee S; Kaldor JM; Page-Shafer K; Moss AR; Schechter MT; Coutinho RA; Keet IP; Van Griensven GJ, 1997, 'Association of age, immunosuppression and AIDS among homosexual men in the Tricontinental Seroconverter Study', Journal of acquired immune deficiency syndrome and human retrovirology, 14, pp. 435 - 441

Hurley SF; Jolley D; Kaldor JM, 1997, 'Effectiveness of needle-exchange programmes for prevention of HIV infection', Lancet, pp. 1797 - 1800

Crofts N; Jolley D; Kaldor JM; Van Beek IA; Wodak AD, 1997, 'Epidemiology of hepatitis C virus infection among injecting drug users in Australia', Journal of Epidemiology and Community Health, 51, pp. 692 - 697

Thackway S; Furner V; Mijch AM; Cooper DA; Holland D; Martinez P; Shaw D; Van Beek IA; Wright E; Clezy KR; Kaldor JM, 1997, 'Fertility and reproductive choice in women with HIV-1 infection', AIDS, 11, pp. 663 - 667

Kaldor JM, 1997, 'Hepatitis B incidence in Australia', Vaccine news, pp. 1 - 2

MacDonald MA; Kaldor JM, 1997, 'Hepatitis C: epidemiology', Australian Chinese Medical Association Journal, 2

Mcnulty A; Li Y; Radtke U; Kaldor JM; Rohrsheim R; Cooper DA; Donovan BJ, 1997, 'Herpes zoster and the stage and prognosis of HIV-1 infection', Genitourinary Medicine, pp. 467 - 470

MacDonald MA; Wodak AD; Ali RL; Crofts N; Cunningham PH; Dolan K; Kelaher M; Loxley W; Van Beek IA; Kaldor JM, 1997, 'HIV prevalence and risk behaviour in need exchange attenders: a natinoal study', Medical Journal of Australia, 166, pp. 237 - 240

Gray JA; Dore GJ; Li Y; Supawitkul S; Effler P; Kaldor JM, 1997, 'HIV-1 infection among female commercial sex workers in rural Thailand', AIDS, 11, pp. 89 - 94

Kaldor JM, 1997, 'HTLV-1 and blood safety: let the community decide', Medical Journal of Australia, 166, pp. 454 - 455

Veugelers PJ; Kaldor JM; Strathdee S; Page-Shafer K; Schechter MT; Coutinho RA; Keet IP; Van Griensven GJ, 1997, 'Incidence and prognostic significance of symptomatic primary immunodeficiency virus type 1 infection in homosexual men', Journal of Infectious Diseases, 176, pp. 112 - 117

Stewart GA; Ashton LJ; Biti RA; Ffrench FA; Bennetts BH; Newcombe NR; Benson EM; Carr AD; Cooper DA; Kaldor JM; Smith DD; Catchpole BR; Allworth A; Baker D; Batty G; Beveridge A; Bloch M; Bodsworth NJ; Clare K; Cummins E; Cunningham PH; Couldwell D; Deacon N; Doong N; Finlayson R; Furner V; Huffam SE; Kidd J; Kelly MD; Lloyd AR; Mcfarlane R; Mclean K; Mcnulty A; Mcphee D; Michelmore H; Mcmurchie M; Mutimer K; Peterson J; Price R; Quan J; Qurn J; Ree H; Robertson M; Roggensack M; Schroeder K; Spencer D; Sullivan JS; Ziegler JB, 1997, 'Increased frequency of CCR-5 delta32 heterozygotes among long-term nonprogressors with HIV infection.', AIDS, 11, pp. 1833 - 1838

Grulich AE; Kaldor JM, 1997, 'Intralesional human chorionic gonadotropin for Kaposi`s sarcoma', New England Journal of Medicine, pp. 1187 - 1188

Van Bentham BH; Veugelers PJ; Schechter MT; Kaldor JM; Page-Shafer K; Van Griensven GJ, 1997, 'Modelling the AIDS incubation time: evaluation of three right censoring strategies', AIDS, 11, pp. 834 - 835

Van De Ven PG; Kippax SC; Crawford J; French J; Prestage G; Grulich AE; Kaldor JM; Kinder P, 1997, 'No relationship between age and HIV risk behaviour among Sydney gay men', AIDS, 11, pp. 691 - 693

Mcdonald A; Cruikshank M; Ziegler JB; Elliott E; Kaldor JM, 1997, 'Perinatal exposure to HIV in Australia 1982-1994', Medical Journal of Australia, 166, pp. 77 - 80

Padiglione A; Goldstein D; Law MG; Hoy JF; Kaldor JM; Mijch AM, 1997, 'Prognosis of Kaposi`s sarcoma as an initial and later AIDS associated illness', Annals of Oncology, pp. 871 - 875

Kaldor JM, 1997, 'Public health epidemiology versus research epidemiology - does it have to be one or the other?', Epidemiologist, pp. 1 - 2

Grulich A; Wan X; Law M; Coates M; Kaldor J, 1997, 'RATES OF NON-AIDS DEFINING CANCERS IN PEOPLE WITH AIDS', Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 14, pp. A18 - A18, http://dx.doi.org/10.1097/00042560-199704010-00049

Law MG; Kaldor JM, 1997, 'Regarding Law MG, Kaldor JM. Survival analysis of randomized clinical trials adjusted for patients who switch treatments. Stat Med 1996;15:2069-2076', Statistics in Medicine, 16, pp. 2620 - 2621

Law MG; Kaldor JM, 1997, 'Regarding Sinicco A, Flora R, Raireri R et al. Is the clinical course of HIV-1 changing?Cohort study. BMJ 1997;314:1232-1237', British Medical Journal: Clinical Research, pp. 1236 - 1237

Grulich AE; Kaldor JM; Hendry O; Luo K; Bodsworth NJ; Cooper DA, 1997, 'Risk of Kaposi`s sarcoma and oroanal sexual contact', American Journal of Epidemiology, 145, pp. 673 - 679

Grulich A; Olsen S; Hendry O; Luo K; Cooper D; Zheng W; Gao S-J; Moore P; Kaldor J, 1997, 'ROUTE OF TRANSMISSION OF KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS', Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 14, pp. A16 - A16, http://dx.doi.org/10.1097/00042560-199704010-00043

Mcnulty A; Rowbottom JH; Kaldor JM, 1997, 'Sentinel sexually transmitted diseases surveillance', Venereology - the Interdisciplinary International Journal of Sexual Health, 10, pp. 10 - 13

Mcnulty A; Rowbottom JH; Kaldor JM, 1997, 'Sentinel sexually transmitted diseases surveillance at sexual health clinics', Venereology - the Interdisciplinary International Journal of Sexual Health, 10, pp. 10 - 13

Van De Ven PG; Kippax SC; Crawford J; French J; Prestage G; Grulich AE; Kaldor JM; Kinder P, 1997, 'Sexual practices in a broad cross-sectional sample of Sydney gay men', Australian and New Zealand Journal of Public Health, pp. 762 - 766

Page-Shafer K; Veugelers PJ; Moss AR; Strathdee S; Kaldor JM; Van Griensven GJ, 1997, 'Sexual risk behaviour and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994', American Journal of Epidemiology, 146, pp. 531 - 542

Dore GJ; Kaldor JM; Mccaughan GW, 1997, 'Systematic review of role of polymerase chain reaction in defining infectiousness among people with hepatitis C virus', British Medical Journal: Clinical Research, pp. 333 - 337

Crofts N; Jolley D; Kaldor JM; Van Beek IA; Wodak AD, 1997, 'The epidemiology of hepatitis C virus infection among injecting drug users in Australia', Journal of Epidemiology and Community Health, pp. 692 - 697

Mcnulty A; Law MG; Bodsworth NJ; Cooper DA; Kaldor JM, 1997, 'The incidence of HIV infection in a cohort of homosexually active men', Australian and New Zealand Journal of Public Health, pp. 587 - 589

Back to profile page